Please enable JavaScript to continue using this application.

Compare $FHTX vs $HURA | Chartloom

Compare

$FHTX vs $HURA

Foghorn Therapeutics Inc · TuHURA Biosciences Inc

FHTX

Foghorn Therapeutics Inc

HURA

TuHURA Biosciences Inc

Compare $FHTX vs $HURA

Comparing Foghorn Therapeutics Inc and TuHURA Biosciences Inc

FHTXFoghorn Therapeutics Inc

HURATuHURA Biosciences Inc

FHTXFoghorn Therapeutics Inc

Market cap

$117M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.04x

Rev growth (TTM)

52.0%

YTD performance

-61.5%

52W performance

-55.6%

FCF yield

-71.8%

HURATuHURA Biosciences Inc

Market cap

$125M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

161.3%

52W performance

-24.9%

FCF yield

-24.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FHTX

HURA

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

HURA

TuHURA Biosciences Inc

Market Cap

FHTX$117M

HURA$125M

Enterprise Value

FHTX$49M

HURA$127M

Price

FHTX$2.00

HURA$1.96

P/E Ratio

FHTXN/A

HURAN/A

P/S Ratio

FHTX3.20x

HURA0.00x

EV/Sales

FHTX1.34x

HURA0.00x

EV/EBITDA

FHTX0.00x

HURA0.00x

P/B Ratio

FHTX1,199.58x

HURA6.58x

P/FCF Ratio

FHTXN/A

HURAN/A

EV/FCF

FHTX-0.59x

HURA-4.26x

PEG Ratio

FHTXN/A

HURAN/A

Forward P/E (NTM)

FHTXN/A

HURAN/A

Forward P/S (NTM)

FHTX4.04x

HURAN/A

Revenue (TTM)

FHTX$37M

HURA$0

Revenue Growth (YoY)

FHTX52.0%

HURAN/A

Forward Rev Growth

FHTX7.3%

HURA197.3%

Gross Margin (TTM)

FHTX0.0%

HURA0.0%

Operating Margin (TTM)

FHTX0.0%

HURA0.0%

EBITDA Margin (TTM)

FHTX-180.6%

HURA0.0%

Net Margin (TTM)

FHTX-175.8%

HURA0.0%

FCF Margin (TTM)

FHTX-229.4%

HURAN/A

Net Income (TTM)

FHTX$-65M

HURA$-31M

FCF (TTM)

FHTX$-84M

HURA$-30M

EPS (TTM)

FHTX-$0.91

HURA-$0.48

ROE (TTM)

FHTX-30161.0%

HURA-15427.0%

ROA (TTM)

FHTX-3117.0%

HURA-10698.0%

ROIC (TTM)

FHTX-30161.0%

HURA-14636.0%

Cash

FHTX$68M

HURA$996K

Debt

FHTX$0

HURA$4M

Net Cash/Debt

FHTX$68M

HURA$-3M

Current Ratio (TTM)

FHTX3.36x

HURA0.18x

Quick Ratio (TTM)

FHTX3.31x

HURA0.16x

Debt/Equity (TTM)

FHTX0.00x

HURA0.19x

Debt/Assets (TTM)

FHTX0.0%

HURA0.0%

Interest Coverage (TTM)

FHTXN/A

HURAN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

HURA0.00x

Beta

FHTX3.13

HURA-0.24

52W Performance

FHTX-55.6%

HURA-24.9%

YTD Performance

FHTX-61.5%

HURA161.3%

% from 52W High

FHTX-73.7%

HURA-42.9%

% from 52W Low

FHTX11.7%

HURA378.0%

Asset Turnover (TTM)

FHTX0.18x

HURA0.00x

FCF Yield (TTM)

FHTX-71.8%

HURA-24.0%

Earnings Yield (TTM)

FHTX-55.0%

HURA-24.5%

Dividend Yield (TTM)

FHTXN/A

HURA0.0%

Rule of 40

FHTX-177.4

HURA0.0

EV/GP/RG

FHTXN/A

HURAN/A

Ticker research

View FHTX research View HURA research

Metric	FHTX Foghorn Therapeutics Inc	HURA TuHURA Biosciences Inc
Market & Valuation
Market Cap	$117M	$125M
Enterprise Value	$49M	$127M
Price	$2.00	$1.96
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	0.00x
EV/Sales	1.34x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	6.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-4.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	52.0%	N/A
Forward Rev Growth	7.3%	197.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	0.0%
Net Margin (TTM)	-175.8%	0.0%
FCF Margin (TTM)	-229.4%	N/A
Net Income (TTM)	$-65M	$-31M
FCF (TTM)	$-84M	$-30M
EPS (TTM)	-$0.91	-$0.48
ROE (TTM)	-30161.0%	-15427.0%
ROA (TTM)	-3117.0%	-10698.0%
ROIC (TTM)	-30161.0%	-14636.0%
Financial Health
Cash	$68M	$996K
Debt	$0	$4M
Net Cash/Debt	$68M	$-3M
Current Ratio (TTM)	3.36x	0.18x
Quick Ratio (TTM)	3.31x	0.16x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	-0.24
52W Performance	-55.6%	-24.9%
YTD Performance	-61.5%	161.3%
% from 52W High	-73.7%	-42.9%
% from 52W Low	11.7%	378.0%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.00x
FCF Yield (TTM)	-71.8%	-24.0%
Earnings Yield (TTM)	-55.0%	-24.5%
Dividend Yield (TTM)	N/A	0.0%
Other
Rule of 40	-177.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View HURA research

Valuation

P/S Ratio

HURA

0.00x

FHTX

3.20x

EV/FCF

HURA

-4.26x

FHTX

-0.59x

Growth & revenue

Revenue Growth TTM

FHTX

52.0%

Forward Revenue Growth

HURA

197.3%

FHTX

7.3%

Profitability & performance

Gross Margin

FHTX

0.0%

HURA

0.0%

ROE

HURA

-15427.0%

FHTX

-30161.0%

FCF Yield %

HURA

-24.0%

FHTX

-71.8%

52-Week Performance

HURA

-24.9%

FHTX

-55.6%

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

HURA

TuHURA Biosciences Inc

Market Cap

FHTX$117M

HURA$125M

Enterprise Value

FHTX$49M

HURA$127M

Price

FHTX$2.00

HURA$1.96

P/E Ratio

FHTXN/A

HURAN/A

P/S Ratio

FHTX3.20x

HURA0.00x

EV/Sales

FHTX1.34x

HURA0.00x

EV/EBITDA

FHTX0.00x

HURA0.00x

P/B Ratio

FHTX1,199.58x

HURA6.58x

P/FCF Ratio

FHTXN/A

HURAN/A

EV/FCF

FHTX-0.59x

HURA-4.26x

PEG Ratio

FHTXN/A

HURAN/A

Forward P/E (NTM)

FHTXN/A

HURAN/A

Forward P/S (NTM)

FHTX4.04x

HURAN/A

Revenue (TTM)

FHTX$37M

HURA$0

Revenue Growth (YoY)

FHTX52.0%

HURAN/A

Forward Rev Growth

FHTX7.3%

HURA197.3%

Gross Margin (TTM)

FHTX0.0%

HURA0.0%

Operating Margin (TTM)

FHTX0.0%

HURA0.0%

EBITDA Margin (TTM)

FHTX-180.6%

HURA0.0%

Net Margin (TTM)

FHTX-175.8%

HURA0.0%

FCF Margin (TTM)

FHTX-229.4%

HURAN/A

Net Income (TTM)

FHTX$-65M

HURA$-31M

FCF (TTM)

FHTX$-84M

HURA$-30M

EPS (TTM)

FHTX-$0.91

HURA-$0.48

ROE (TTM)

FHTX-30161.0%

HURA-15427.0%

ROA (TTM)

FHTX-3117.0%

HURA-10698.0%

ROIC (TTM)

FHTX-30161.0%

HURA-14636.0%

Cash

FHTX$68M

HURA$996K

Debt

FHTX$0

HURA$4M

Net Cash/Debt

FHTX$68M

HURA$-3M

Current Ratio (TTM)

FHTX3.36x

HURA0.18x

Quick Ratio (TTM)

FHTX3.31x

HURA0.16x

Debt/Equity (TTM)

FHTX0.00x

HURA0.19x

Debt/Assets (TTM)

FHTX0.0%

HURA0.0%

Interest Coverage (TTM)

FHTXN/A

HURAN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

HURA0.00x

Beta

FHTX3.13

HURA-0.24

52W Performance

FHTX-55.6%

HURA-24.9%

YTD Performance

FHTX-61.5%

HURA161.3%

% from 52W High

FHTX-73.7%

HURA-42.9%

% from 52W Low

FHTX11.7%

HURA378.0%

Asset Turnover (TTM)

FHTX0.18x

HURA0.00x

FCF Yield (TTM)

FHTX-71.8%

HURA-24.0%

Earnings Yield (TTM)

FHTX-55.0%

HURA-24.5%

Dividend Yield (TTM)

FHTXN/A

HURA0.0%

Rule of 40

FHTX-177.4

HURA0.0

EV/GP/RG

FHTXN/A

HURAN/A

Ticker research

View FHTX research View HURA research

Metric	FHTX Foghorn Therapeutics Inc	HURA TuHURA Biosciences Inc
Market & Valuation
Market Cap	$117M	$125M
Enterprise Value	$49M	$127M
Price	$2.00	$1.96
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	0.00x
EV/Sales	1.34x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	6.58x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-4.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	52.0%	N/A
Forward Rev Growth	7.3%	197.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	0.0%
Net Margin (TTM)	-175.8%	0.0%
FCF Margin (TTM)	-229.4%	N/A
Net Income (TTM)	$-65M	$-31M
FCF (TTM)	$-84M	$-30M
EPS (TTM)	-$0.91	-$0.48
ROE (TTM)	-30161.0%	-15427.0%
ROA (TTM)	-3117.0%	-10698.0%
ROIC (TTM)	-30161.0%	-14636.0%
Financial Health
Cash	$68M	$996K
Debt	$0	$4M
Net Cash/Debt	$68M	$-3M
Current Ratio (TTM)	3.36x	0.18x
Quick Ratio (TTM)	3.31x	0.16x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	-0.24
52W Performance	-55.6%	-24.9%
YTD Performance	-61.5%	161.3%
% from 52W High	-73.7%	-42.9%
% from 52W Low	11.7%	378.0%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.00x
FCF Yield (TTM)	-71.8%	-24.0%
Earnings Yield (TTM)	-55.0%	-24.5%
Dividend Yield (TTM)	N/A	0.0%
Other
Rule of 40	-177.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View HURA research